Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Bakuchiol has in vitro antimicrobial activity against oral pathogens

Dec. 17, 2001

Positive data presented for OC-1016, a novel bone- and tissue-regenerating agent

Oct. 10, 2001

CollaGenex to market dental products from Atrix in the U.S.

Aug. 30, 2001

Graft material for oral mucosal defects

Aug. 30, 2001

Periostat tablets for periodontitis granted dental practitioners formulary status in the UK

Aug. 14, 2001

Biora enters distribution agreement with USBiomaterials for new periodontal disease product

Aug. 10, 2001

Atridox receives approval in Switzerland

July 9, 2001

CollaGenex launches tablet formulation of Periostat

July 3, 2001

CollaGenex seeks pan-European approval for Periostat tablets

June 20, 2001

Role for melatonin in Rx of periodontal disease discussed at IBMS/ECTS meeting

June 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...